These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 34817756

  • 1. Neuroprotective effects of liraglutide against inflammation through the AMPK/NF-κB pathway in a mouse model of Parkinson's disease.
    Cao B, Zhang Y, Chen J, Wu P, Dong Y, Wang Y.
    Metab Brain Dis; 2022 Feb; 37(2):451-462. PubMed ID: 34817756
    [Abstract] [Full Text] [Related]

  • 2. The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease.
    Zhang L, Zhang L, Li Y, Li L, Melchiorsen JU, Rosenkilde M, Hölscher C.
    J Parkinsons Dis; 2020 Feb; 10(2):523-542. PubMed ID: 31958096
    [Abstract] [Full Text] [Related]

  • 3. A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
    Yuan Z, Li D, Feng P, Xue G, Ji C, Li G, Hölscher C.
    Eur J Pharmacol; 2017 Oct 05; 812():82-90. PubMed ID: 28666800
    [Abstract] [Full Text] [Related]

  • 4. Dexmedetomidine alleviates pain in MPTP-treated mice by activating the AMPK/mTOR/NF-κB pathways in astrocytes.
    Chen Y, Li Y, Li C, Zhu D, Cheng O, Cui J.
    Neurosci Lett; 2022 Nov 20; 791():136933. PubMed ID: 36283628
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK/SIRT1 signaling and NLRP3 inflammasome.
    Ammar RA, Mohamed AF, Kamal MM, Safar MM, Abdelkader NF.
    Inflammopharmacology; 2022 Jun 20; 30(3):919-934. PubMed ID: 35364735
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model.
    Zhang L, Zhang L, Li L, Hölscher C.
    Neuropeptides; 2018 Oct 20; 71():70-80. PubMed ID: 30017231
    [Abstract] [Full Text] [Related]

  • 7. GLP-1 analogue liraglutide attenuates CIH-induced cognitive deficits by inhibiting oxidative stress, neuroinflammation, and apoptosis via the Nrf2/HO-1 and MAPK/NF-κB signaling pathways.
    Lv R, Zhao Y, Wang X, He Y, Dong N, Min X, Liu X, Yu Q, Yuan K, Yue H, Yin Q.
    Int Immunopharmacol; 2024 Dec 05; 142(Pt B):113222. PubMed ID: 39321702
    [Abstract] [Full Text] [Related]

  • 8. Bear bile powder alleviates Parkinson's disease-like behavior in mice by inhibiting astrocyte-mediated neuroinflammation.
    Wang L, Bai Y, Tao Y, Shen W, Zhou H, He Y, Wu H, Huang F, Shi H, Wu X.
    Chin J Nat Med; 2023 Sep 05; 21(9):710-720. PubMed ID: 37777320
    [Abstract] [Full Text] [Related]

  • 9. Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models.
    Su Y, Liu N, Zhang Z, Li H, Ma J, Yuan Y, Shi M, Liu J, Zhao Z, Zhang Z, Holscher C.
    Eur J Pharmacol; 2022 Jul 05; 926():175029. PubMed ID: 35584709
    [Abstract] [Full Text] [Related]

  • 10. Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice.
    Lv Y, Zhang Z, Hou L, Zhang L, Zhang J, Wang Y, Liu C, Xu P, Liu L, Gai X, Lu T.
    Neurosci Lett; 2015 Jun 15; 597():132-6. PubMed ID: 25929185
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Liu W, Jalewa J, Sharma M, Li G, Li L, Hölscher C.
    Neuroscience; 2015 Sep 10; 303():42-50. PubMed ID: 26141845
    [Abstract] [Full Text] [Related]

  • 12. Calycosin attenuates MPTP-induced Parkinson's disease by suppressing the activation of TLR/NF-κB and MAPK pathways.
    Yang J, Jia M, Zhang X, Wang P.
    Phytother Res; 2019 Feb 10; 33(2):309-318. PubMed ID: 30421460
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotective Effects of a GLP-2 Analogue in the MPTP Parkinson's Disease Mouse Model.
    Zhang Z, Hao L, Shi M, Yu Z, Shao S, Yuan Y, Zhang Z, Hölscher C.
    J Parkinsons Dis; 2021 Feb 10; 11(2):529-543. PubMed ID: 33523018
    [Abstract] [Full Text] [Related]

  • 14. Mitochonic acid 5 ameliorates the motor deficits in the MPTP-induced mouse Parkinson's disease model by AMPK-mediated autophagy.
    Wan J, Gao Y, Tan J, Yi S, Huang K, Liu Y, Chang D, Xie J, Chen S, Wu H.
    Folia Neuropathol; 2022 Feb 10; 60(3):329-337. PubMed ID: 36382486
    [Abstract] [Full Text] [Related]

  • 15. [P38 MAPK signaling pathway regulates nuclear factor-κB and inducible nitric oxide synthase expressions in the substantia nigra in a mouse model of Parkinson's disease].
    Wang Q, Zhang H, Liu M, Zhang Z, Wei Z, Sun N, Mao T, Zhang Y.
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul 10; 34(8):1176-80. PubMed ID: 25176090
    [Abstract] [Full Text] [Related]

  • 16. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
    Park JE, Leem YH, Park JS, Kim DY, Kang JL, Kim HS.
    Int J Mol Sci; 2022 Apr 16; 23(8):. PubMed ID: 35457238
    [Abstract] [Full Text] [Related]

  • 17. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.
    Atiq A, Lee HJ, Khan A, Kang MH, Rehman IU, Ahmad R, Tahir M, Ali J, Choe K, Park JS, Kim MO.
    Int J Mol Sci; 2023 Jun 09; 24(12):. PubMed ID: 37373089
    [Abstract] [Full Text] [Related]

  • 18. Liraglutide Regulates Mitochondrial Quality Control System Through PGC-1α in a Mouse Model of Parkinson's Disease.
    Wu P, Dong Y, Chen J, Guan T, Cao B, Zhang Y, Qi Y, Guan Z, Wang Y.
    Neurotox Res; 2022 Feb 09; 40(1):286-297. PubMed ID: 35043376
    [Abstract] [Full Text] [Related]

  • 19. Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson's disease.
    Guo L, Li Y, Li W, Qiu J, Du J, Wang L, Zhang T.
    Clin Exp Pharmacol Physiol; 2022 Nov 09; 49(11):1221-1231. PubMed ID: 36054693
    [Abstract] [Full Text] [Related]

  • 20. Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease.
    Zhang L, Zhang L, Li L, Hölscher C.
    J Parkinsons Dis; 2019 Nov 09; 9(1):157-171. PubMed ID: 30741689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.